Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526747 · ClinicalTrials.gov registry record
Erythropoietin Resistance in Anemia of Chronic Kidney Disease
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 32
- Enrollment target
NCT00526747: Completed study, sponsored by Duke University.
NCT00526747 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00526747 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-06 |
What the finished NCT00526747 record still lists
NCT00526747 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00526747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00526747 about?
NCT00526747 is a clinical study titled "Erythropoietin Resistance in Anemia of Chronic Kidney Disease". Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
What is the current status of trial NCT00526747?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2007-08. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00526747?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia